Dermata Therapeutics is a clinical-stage company based in California, specializing in medical dermatology. Their focus is on developing and commercializing pharmaceutical products for treating a wide range of skin conditions and diseases. With a strong emphasis on innovation, Dermata aims to identify and develop effective products through clinical trials. Currently, they are exploring the potential of a unique botanical product with multiple mechanisms of action to treat acne. Founded in 2014, Dermata utilizes its proprietary Spongilla technology platform to create topical treatments for various inflammatory skin diseases, enabling targeted delivery of chemical compounds into the dermis for maximum treatment effectiveness.